Zobrazeno 1 - 10
of 35
pro vyhledávání: '"N Yu, Lukianova"'
Autor:
O. O. Shevchuk, I. M. Todor, N. Yu. Lukianova, N. K. Rodionova, V. G. Nikolaev, V. F. Chekhun
Publikováno v:
International Journal of Medicine and Medical Research, Vol 5, Iss 1, Pp 66-74 (2019)
Background. Side effects of antineoplastic agents (especially leukopenia and neutropenia) could be the main limiting factors for efficient treatment. Objective. The research is aimed at the study of myeloprotective capability of biosimilars of gra
Externí odkaz:
https://doaj.org/article/d4054e6bf3ad4e68b86296616f2aef95
Autor:
V. F. Chekhun, Yu. V. Lozovska, A. P. Burlaka, I. I. Ganusevich, Yu. V. Shvets, N. Yu. Lukianova, I. M. Todor, D. V. Demash, A. A. Pavlova, L. A. Naleskina
Publikováno v:
The Ukrainian Biochemical Journal, Vol 87, Iss 2, Pp 103-112 (2015)
The study was focused on the detection of changes in serum and tumor metal-containing proteins in animals during development of doxorubicin-resistant phenotype in malignant cells after 12 courses of chemotherapy. We found that on every stage of resis
Externí odkaz:
https://doaj.org/article/1921361976924d928f68b362b595f6c8
Autor:
P A, Virych, T V, Zadvorniy, T V, Borikun, O O, Lykhova, V A, Chumachenko, V A, Pavlenko, N V, Kutsevol, N Yu, Lukianova
Publikováno v:
Experimental oncology. 44(3)
The combination of zinc oxide (ZnO) nanoparticles (NPs) with carriers enhances the anticancer effect of nanocomposites.To explore the mechanisms of cytotoxic action of dextran-graft-polyacrylamide (D-g-PAA/ZnO) NPs against prostate cancers cell lines
Autor:
І.М. Todor, І.М. Andrusishуna, Yu V Lozovska, І.І. Ganusevych, N Yu Lukianova, A P Burlaka, Vasyl F. Chekhun
Publikováno v:
Fiziolohichnyĭ zhurnal. 66:20-29
The content of the essential macro- and microelements (MaE and ME) – copper, zinc, magnesium, iron and calcium was measured in blood plasma (BP) and tumor tissue (TT) of the animals engrafted with Walker 256 carcinosarcoma (tumor strains sensitive
Autor:
I.M. Andrusishina, T.V. Zadvorniy, L. M. Kunska, E.O. Stakhovskiy, I.V. Zhulkevych, Yu V Lozovska, N Yu Lukianova, L. A. Naleskina
Publikováno v:
Fiziolohichnyĭ zhurnal. 65:70-80
Autor:
N. Yu. Lukianova, I. M. Todor, Vasyl F. Chekhun, V. G. Nikolaev, N. K. Rodionova, O. O. Shevchuk
Publikováno v:
International Journal of Medicine and Medical Research, Vol 5, Iss 1, Pp 66-74 (2019)
Background. Side effects of antineoplastic agents (especially leukopenia and neutropenia) could be the main limiting factors for efficient treatment. Objective. The research is aimed at the study of myeloprotective capability of biosimilars of granul
Autor:
N M Glushchenko, Miriam Mints, Vasyl F. Chekhun, N Yu Lukianova, L G Buchynska, Elena Kashuba, N P Iurchenko, O V Brieieva
Publikováno v:
Experimental Oncology. 40:303-308
Background: Recent studies allow to consider the mitochondrial ribosomal protein S18-2 (MRPS18-2, S18-2) as a potential oncoprotein, which suggests the need for further characterization of its expression in tumors of different genesis including breas
Publikováno v:
Experimental Oncology. 42
AIM In order to develop fundamentally new technologies for non-invasive and safer diagnosis of cancer, we aimed to detect non-contact magnetic signals from a malignant tumor in animals treated or not-treated with the ferromagnetic nanocomposite Ferro
Publikováno v:
Experimental Oncology. 42
The variability of the clinical course of prostate cancer (PC) indicates the need to find factors that could predict the aggressive potential of neoplasms accounting the biological characteristics of tumor cells. In this context, the role of NANOG, a
Autor:
I.V. Shepelenko, Vasyl F. Chekhun, Bazas Vm, N. A. Bezdenezhnykh, A.N. Klyusov, N Yu Lukianova, T V Borikun
Publikováno v:
Science and innovation. 13:63-69